Cellectar Biosciences Inc (CLRB)
3.30
-0.03
(-0.90%)
USD |
NASDAQ |
May 17, 16:00
3.295
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Total Assets (Quarterly): 42.91M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 42.91M |
December 31, 2023 | 12.08M |
September 30, 2023 | 21.55M |
June 30, 2023 | 6.509M |
March 31, 2023 | 14.84M |
December 31, 2022 | 21.59M |
September 30, 2022 | 19.32M |
June 30, 2022 | 25.89M |
March 31, 2022 | 31.99M |
December 31, 2021 | 37.20M |
September 30, 2021 | 41.95M |
June 30, 2021 | 47.74M |
March 31, 2021 | 55.06M |
December 31, 2020 | 58.66M |
September 30, 2020 | 20.70M |
June 30, 2020 | 23.85M |
March 31, 2020 | 8.690M |
December 31, 2019 | 12.25M |
September 30, 2019 | 15.66M |
June 30, 2019 | 19.14M |
March 31, 2019 | 12.55M |
December 31, 2018 | 15.05M |
September 30, 2018 | 19.54M |
June 30, 2018 | 6.997M |
March 31, 2018 | 9.561M |
Date | Value |
---|---|
December 31, 2017 | 12.87M |
September 30, 2017 | 9.871M |
June 30, 2017 | 12.60M |
March 31, 2017 | 15.30M |
December 31, 2016 | 15.32M |
September 30, 2016 | 9.296M |
June 30, 2016 | 11.38M |
March 31, 2016 | 5.570M |
December 31, 2015 | 7.596M |
September 30, 2015 | 6.462M |
June 30, 2015 | 8.580M |
March 31, 2015 | 10.91M |
December 31, 2014 | 13.42M |
September 30, 2014 | 15.72M |
June 30, 2014 | 5.889M |
March 31, 2014 | 8.040M |
December 31, 2013 | 6.816M |
September 30, 2013 | 9.647M |
June 30, 2013 | 12.12M |
March 31, 2013 | 14.31M |
December 31, 2012 | 11.48M |
September 30, 2012 | 10.39M |
June 30, 2012 | 11.85M |
March 31, 2012 | 8.648M |
December 31, 2011 | 10.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.509M
Minimum
Jun 2023
58.66M
Maximum
Dec 2020
26.88M
Average
21.57M
Median
Total Assets (Quarterly) Benchmarks
Perspective Therapeutics Inc | 278.29M |
Eli Lilly and Co | 63.94B |
Actinium Pharmaceuticals Inc | 88.35M |
Bristol-Myers Squibb Co | 99.03B |
Altimmune Inc | 188.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 16.74M |
Shareholders Equity (Quarterly) | 26.17M |